Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Expected timeline: Similar pattern to topical-only but potentially accelerated and more pronounced results due to enhanced absorption
Due to the ongoing need for a treatment for Wolfram syndrome, the authors have aimed to evaluate the therapeutic potential of glucagon-like peptide 1 receptor (GLP-1R) agonists under WFS1 deficiency with a particular focus on human beta cells and neurons. By comparing the effects of GLP-1R agonists in mice and human preclinical models with Wolfram syndrome, their research provides evidence supporting that GLP-1R agonists on WFS1-deficient human pancreatic beta cells and neurons are beneficial
Experts are firmly in the food-first camp real food provides fiber, protein and other nutrients that no supplement can replicate but GLP-1 supplements are often worth considering
Note: This is intended as a guide only
The dose for weight loss is usually lower than the dose used for diabetes management
, , 12
